Validity and responsiveness of Patient-reported outcomes Common Terminology Criteria for Adverse Events (PRO-CTCAE) in the ovarian cancer (OC) cohort of the FICOG VIP study.

The use of PROs is recommended by regulatory authorities for improving patient care. The VIP (Validation of Italian PRO-CTCAE, NCT04416672) study, promoted by FICOG (Federation of Italian Cooperative Oncology Groups), is testing psychometric properties of PRO-CTCAE for different cancer types in Italy. Here we report the dataset of the OC cohort